FAVHIV .: A composition for use in a method for prevention or treatment of human immunodefitiency virus infections (Q2906304): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
(Removed claim: co-financing rate (P837): 66.0 percent, Removing co-finance rate from projects in portugal) |
||||||
| Property / co-financing rate | |||||||
| |||||||
| Property / co-financing rate: 66.0 percent / rank | |||||||
Revision as of 11:21, 14 September 2021
Project Q2906304 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FAVHIV .: A composition for use in a method for prevention or treatment of human immunodefitiency virus infections |
Project Q2906304 in Portugal |
Statements
5,493.77 Euro
0 references
7 November 2016
0 references
6 November 2017
0 references
INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA
0 references
Q2993187 (Deleted Item)
0 references
41°8'58.02"N, 8°36'38.84"W
0 references
Porto
0 references
Identifiers
POCI-01-0145-FEDER-026103
0 references